Purchase Order 1333ND22PNB640093

Award Date 4/1/22
Potential Completion Date 3/31/27
Potential Value $552K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Neffsville, PA 17601, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $45,365 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for the analysis of three compounds in a panel of 50 customized cancer cell lines over a three-month period. The work aims to evaluate the effects of the compounds on cell proliferation, cell death, caspase activity, and...
This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
This is a firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the Department of Health and Human Services, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract has a total ceiling value of $659,400.00 and a period of performance through September 11, 2024. It was issued under the NIAID's "Nonclinical Services for Development of Interventional Agents"...
This is a firm-fixed-price purchase order worth $20,979.04 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for binding studies with a period of performance through August 10, 2024. Eurofins Panlabs has received numerous federal contract awards from agencies like NIH, EPA, FDA, and VA to provide...
This is a $541,498.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract provides nonclinical services in support of the development of interventional agents, and is issued under the Nonclinical Services for Development of Interventional Agents indefinite delivery,...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The $1,212,720.00 firm-fixed-price contract is for nonclinical services to support the development of interventional agents for infectious diseases. It is a task order under a larger NIAID indefinite delivery vehicle (IDV) contract for nonclinical services for the development of...
The Department of Commerce National Institute of Standards and Technology (NIST) awarded a $2,214,773.00 Firm Fixed Price Purchase Order to the Standards Coordinating Body For Gene Cell & Regenerative Medicines, a Non-Profit Organization, for the development of STANDARDS DEVELOPMENT FOR REGENERATIVE MEDICINE THERAPIES. The contract has a completion date of May 2, 2026 and does not utilize a set-aside designation. This work supports NIST's role in developing standards and measurement tools to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $464,720.00 firm fixed price delivery order contract to Eurofins Panlabs, Inc. for nonclinical services to support the development of interventional agents for infectious diseases. The contract is associated with a larger indefinite delivery/indefinite quantity (IDIQ) vehicle titled "Nonclinical Services for Development of Interventional Agents."...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Task Order E06 "Custom Screening Assays for Metabolic Stability and Peptidase Selectivity" to Eurofins Panlabs, Inc. for $359,026.82 on a firm fixed price basis. This task order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity (IDIQ) contract. Eurofins Panlabs, Inc. is a contract...
This task order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Nonclinical Services for Development of Interventional Agents. The task order, valued at $102,981.15, is for "Lead Optimization Screening Assays for Safety Profiling" and has a total potential value of $137,856.75. Eurofins Panlabs, a foreign-owned for-profit...

The National Institute of Standards and Technology (NIST) awarded a $552,092.56 firm-fixed price purchase order to Eurofins Lancaster Laboratories Inc. to prepare and characterize 200 vials of a NISTCHO master cell bank and 800 vials of a NISTCHO working cell bank. This requirement was originally solicited as an open market procurement, with no set-aside designation. Eurofins, a for-profit organization that provides testing and support services to various industries, will complete this 24-month effort using government-furnished research cell bank material. The contractor must conduct extensive sterility, mycoplasma, and adventitious agent testing according to current good manufacturing practices and international standards prior to delivering the cell banks to NIST in Gaithersburg, Maryland. This purchase order is not associated with a larger contracting vehicle.

Generated 6/30/24, 12:36 AM